Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.

about

Human Granzyme B Based Targeted Cytolytic Fusion Proteins.

P2860

Q55647066-36C608B3-D258-4820-833B-F339D421127D

P2860

Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.

Item

http://www.wikidata.org/entity/Q38699173

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Novel PSCA targeting scFv-fusi ...... unotherapy of prostate cancer.

@en

type

Item

label

Novel PSCA targeting scFv-fusi ...... unotherapy of prostate cancer.

@en

prefLabel

Novel PSCA targeting scFv-fusi ...... unotherapy of prostate cancer.

@en

P1476

Novel PSCA targeting scFv-fusi ...... unotherapy of prostate cancer.

@en

P2093

Alessa Pardo

http://www.w3.org/2001/XMLSchema#string

Claudia Kessler

http://www.w3.org/2001/XMLSchema#string

Katharina Kolberg

http://www.w3.org/2001/XMLSchema#string

Rainer Fischer

http://www.w3.org/2001/XMLSchema#string

Stefan Gattenlöhner

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer

The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials

From bench to bedside: immunotherapy for prostate cancer

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

Prostate stem cell antigen is overexpressed in prostate cancer metastases

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.

Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors.

P2888

s00432-017-2472-9

P304

2025-2038

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-017-2472-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Barth

Mehmet K Tur

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28667390

http://www.w3.org/2001/XMLSchema#string

Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.

about

P2860

P2860

Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698